Definitive Contract HHSD200201692351C
Award Date
9/29/16
Potential Completion Date
12/28/19
Potential Value
$749K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
State Of California Controllers Office
NAICS Category
611310 - Colleges, Universities, and Professional Schools
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Vietnam
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,724,262 definitive cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for the Tuberculosis Trials Consortium. The contract has a completion date of December 31, 2021 and is not set aside for any special program. UCSF is an academic institution that has previously received federal contracts and grants from agencies such as the National Institutes of Health,...
This federal contract award to Kaiser Foundation Hospitals, a subsidiary of Kaiser Foundation Health Plan, Inc., supports the Centers for Disease Control and Prevention's (CDC) efforts to improve identification and treatment of latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. The $5,223,415 definitive contract, awarded on September 29, 2021 without a set-aside, will fund the development, implementation, and evaluation of LTBI intervention...
This is a Definitive Contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to the National Hospital for Tropical Diseases. The $1,093,878.94 firm-fixed-price contract is for a VIETNAM STUDY: RICKETTSIAL DISEASES, SCRUB TYPHUS AND Q FEVER. The contract has an ultimate completion date of April 15, 2022 and was awarded on April 14, 2018. The contract does not have a set-aside designation. Based on the agency and nature of the work, this contract...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division, a U.S. state government entity, to support the Tuberculosis Epidemiology Studies Consortium. The contract has a ceiling value of $4,178,577.57 and runs through September 2021. It is a cost-no-fee contract type, with no set-aside designation. The contract provides for a comparison of tuberculin skin tests (TST) versus...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF), a leading academic medical center and research institution. The contract, valued at $300,058, is for other functions and is a definitive, firm-fixed-price contract. It does not have a set-aside designation. The contract work is being performed in Atlanta, Georgia and has an ultimate completion date of December 31, 2018. UCSF has a strong...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price definitive contract to the Hennepin Healthcare Research Institute (HHRI), a non-profit research organization, to conduct a tuberculosis (TB) clinical trial in Minneapolis, Minnesota. The $137,793.25 contract has a completion date of February 28, 2023. HHRI is a division of Hennepin County, the local government entity that provides a range of services to federal agencies, including public health, public...
The U.S. Department of Health and Human Services (HHS) awarded a $5,099,064.36 delivery order contract to Denver Health and Hospital Authority (Denver Health) to conduct a study comparing tuberculosis skin tests (TST) and interferon-gamma release assays (IGRAs) in latent tuberculosis infection (LTBI) patients. The contract was issued under the Tuberculosis Epidemiology Studies Consortium, a larger indefinite delivery vehicle held by HHS. The award did not utilize any set-aside designations....
This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $146,040.00 firm fixed-price purchase order to the National Institute For Research In Tuberculosis, a non-profit organization and hospital in India. The contract is for "EARLY BATERICIDAL ACTIVITY (EBA) OF ANTI-TB DRUGS IN INDIA." The award does not have a set-aside designation. Based on the awardee's background, it appears the National Institute For Research In Tuberculosis is providing...